MEDIA STATEMENT - msd-uk.com
- 2 - Notes to editors About MSD For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for the world’s most challenging diseases.
Download MEDIA STATEMENT - msd-uk.com
Information
Domain:
Source:
Link to this page:
Documents from same domain
MEDIA STATEMENT - msd-uk.com
www.msd-uk.comMEDIA STATEMENT UNDER STRICT EMBARGO: 00:01 HOURS, 27 MONDAY 2017 MSD announces plan to establish UK Discovery Centre in London MSD, known as Merck & Co., Inc., of Kenilworth, NJ, USA in the US and Canada, has today
MEDIA STATEMENT - msd-uk.com
www.msd-uk.comCORP-1246670-0000 Meral Nugent 1 Feb 2018. MEDIA STATEMENT. For immediate release . MSD certified as one of the Top Employers United Kingdom 2018 . 1 February 2018: London– MSD (a trade name of Merck & Co., Inc., with headquarters in Kenilworth, NJ, USA) is proud to announce that it has been officially certified by the Top Employers
Related documents
An Analysis of the US Biosimilars Development …
www.biopharma.com18 BioProcess International 11(6)s Ju n e 2013 Supplement proteins, with this information now integrated into the BIOPHARMA (reference products) database (7) • continuous compiling all biosimilars and biobetters reported in
china-biopartners The Top-60 Chinese Biopharma …
www.bioplanassociates.comnies in R&D and production has provided opportunities for Chinese biotechs to gain management know-how from their Western partners. As an emerging biophar-
Reliable Fisher Control Valve Solutions - Emerson
www.emerson.comReliable Fisher ® Control Valve Solutions Achieve greater success by partnering with Emerson
profile - PhRMA – 米国研究製薬工業協会
www.phrma-jp.orgIMPROVING OUTCOMES FOR PATIENTS Better Results: The Impact of Today’s Medicines T oday’s medicines – the results of decades of biopharmaceutical R&D – are making important contribu-
Corporate Presentation (1177.HK) - sinobiopharm.com
www.sinobiopharm.com2 Corporate Overview Business Profile Share Data Engaged in the R&D, manufacturing and marketing of a wide range of modernized Chinese medicines and chemical medicines Main therapeutic areas include hepatitis, cardio-cerebral diseases, oncology,
Letter from the CEO - Australian Securities Exchange
www.asx.com.auOn behalf of MGC Pharmaceuticals’ Board and myself, I would like to take the opportunity to thank you for all your support since I stepped up to the role of CEO in May 2017.
Cipla EU divests stake in Chase Pharmaceuticals to …
www.cipla.comPress Release Cipla EU divests stake in Chase Pharmaceuticals to Allergan ~ Chase’s lead Alzheimer’s dementia drug CPC-201 successfully completed Phase 2 and is ready for further clinical development